Bacterial contamination of growth hormone solution and injection equipment during use by growth hormone deficient children.

What Was Tested

The paper reports a study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over), published as a randomized controlled trial.

Who Took Part

The study group was 20 children.

The age groups tagged for this paper are children and teenagers, both men and women.

In a cross-over study the children were randomized to begin using, for their growth hormone injections, either the recently developed growth hormone injection pen or the conventional syringe method.

How the Study Was Run

The researchers set it up as a randomized and crossover study.

The children were allocated by chance, so the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) group and the comparison group should start out alike.

In the crossover set-up each of the children took both Exogenous HGH, sermorelin & older GHRPs (why they're passed over) and the comparison in turn, acting as their own control.

What Was Measured

PubMed files the paper under topics including Bacteria, Chi-Square Distribution, Drug Contamination, Equipment Contamination, Growth Disorders, Growth Hormone and Solutions.

What This Means in Plain Language

The paper is a randomized and crossover study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 20 children.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The publication is from 1991 (The Journal of hospital infection), a journal based in England.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.